Muscarinic Acetylcholine Receptor Knockout Mice
J. Wess,W. Zhang,A. Duttaroy,T. Miyakawa,J. Gomeza,Y. Cui,A. S. Basile,F. P. Bymaster,D. L. McKinzie,C. C. Felder,C. Deng,M. Yamada
DOI: https://doi.org/10.1007/978-3-642-18934-0_3
2004-01-01
Abstract:
Muscarinic acetylcholine receptors (mAChRs) play critical roles in regulating the activity of many important functions of
the central and peripheral nervous system. However, identification of the physiological and pathophysiological roles of the
individual mAChR subtypes (M1-M5) has proven a difficult task, primarily due to the lack of ligands endowed with a high degree of receptor subtype selectivity
and the fact that most tissues and organs express multiple mAChRs. To circumvent these difficulties, we and others have used
gene targeting strategies to generate mutant mouse lines containing inactivating mutations of the M1-M5 mAChR genes. The different mAChR mutant mice and the corresponding wild-type control animals were subjected to a battery
of physiological, pharmacological, behavioral, biochemical, and neurochemical tests. The M1-M5 mAChR mutant mice (MXR-/- mice) were all viable and reproduced normally. However, each mutant mouse line displayed distinct
phenotypical changes. For example, M1R-/- mice showed a pronounced increase in locomotor activity, probably due to the increase
in dopamine release in the striatum. In addition, pilocarpine-induced epileptic seizures were absent in M1R-/- mice. Pharmacological
analysis of M2R-/- mice indicated that the M2 subtype plays a key role in mediating three of the most striking central muscarinic effects: tremor, hypothermia, and analgesia.
As expected, muscarinic agonist-mediated bradycardia was abolished in M2R-/- mice. M3R-/- mice displayed a significant decrease
in food intake, reduced body weight and peripheral fat deposits, and very low serum leptin and insulin levels. Additional
studies showed that the M3 receptor subtype also plays a key role in mediating smooth muscle contraction and glandular secretion. Behavioral analysis
of M4R-/- mice suggested that M4 receptors mediate inhibition of D1 dopamine receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons. Studies with M5R-/-
mice indicated that vascular M5 receptors mediate cholinergic relaxation of cerebral arteries and arterioles. Behavioral and neurochemical studies showed
that M5 receptor activity modulates both morphine reward and withdrawal processes, probably through activation of M5 receptors located on midbrain dopaminergic neurons. These results offer promising new perspectives for the rational development
of novel muscarinic drugs.